Status: current, Defined. Date: 31-Jan 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4664691000168118 | Mesalazine (Takeda) (mesalazine 1.2 g) modified release tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4664701000168118 | Mesalazine (Takeda) 1.2 g modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mesalazine (Takeda) 1.2 g modified release tablet | Is a | Mesalazine (Takeda) | true | Inferred relationship | Some | ||
| Mesalazine (Takeda) 1.2 g modified release tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Mesalazine (Takeda) 1.2 g modified release tablet | Is a | mesalazine 1.2 g modified release tablet | true | Inferred relationship | Some | ||
| Mesalazine (Takeda) 1.2 g modified release tablet | has manufactured dose form | modified release tablet | true | Inferred relationship | Some | ||
| Mesalazine (Takeda) 1.2 g modified release tablet | has Australian BoSS | mesalazine | true | Inferred relationship | Some | 955441373 | |
| Mesalazine (Takeda) 1.2 g modified release tablet | has intended active ingredient | mesalazine | true | Inferred relationship | Some | 955441373 | |
| Mesalazine (Takeda) 1.2 g modified release tablet | has unit of use | tablet | true | Inferred relationship | Some | 1836884911 |
Reference Sets
Description inactivation indicator reference set
Trade product unit of use reference set
FHIR